Selected research
Market Analysis & Forecast
Global GMP Grade Viral Service Market Analysis and Forecast 2026-2032
Market perspective
The global GMP Grade Viral Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for GMP Grade Viral Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for GMP Grade Viral Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for GMP Grade Viral Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for GMP Grade Viral Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of GMP Grade Viral Service include AGC Biologics, Andelyn Biosciences, Catalent, Charles River Laboratories, CoJourney Inc, Creative Biogene, Flash-biosolutions, Lonza and ProBio CDMO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for GMP Grade Viral Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of GMP Grade Viral Service, also provides the revenue of main regions and countries. Of the upcoming market potential for GMP Grade Viral Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the GMP Grade Viral Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global GMP Grade Viral Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for GMP Grade Viral Service revenue, projected growth trends, production technology, application and end-user industry.
GMP Grade Viral Service Segment by Company
AGC Biologics
Andelyn Biosciences
Catalent
Charles River Laboratories
CoJourney Inc
Creative Biogene
Flash-biosolutions
Lonza
ProBio CDMO
ProBioGen AG
Sartorius Stedim Biotech
Takara Bio
Thermo Fisher Scientific
uBriGene
VectorBuilder
WuXi Advanced Therapies
GMP Grade Viral Service Segment by Type
Viral Vector Process Development Service
Gmp Manufacturing and Release Service
Analytical Method Development and Quality Research Service
Others
GMP Grade Viral Service Segment by Application
Gene Therapy and Cell Therapy Industry
Tumor Immunotherapy Industry
Vaccine Industry
Diagnostics Industry
Others
GMP Grade Viral Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Grade Viral Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Grade Viral Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Grade Viral Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of GMP Grade Viral Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of GMP Grade Viral Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GMP Grade Viral Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Viral Vector Process Development Service
- Gmp Manufacturing and Release Service
- Analytical Method Development and Quality Research Service
- Others
Applications
- Gene Therapy and Cell Therapy Industry
- Tumor Immunotherapy Industry
- Vaccine Industry
- Diagnostics Industry
- Others
Companies covered
- AGC Biologics
- Andelyn Biosciences
- Catalent
- Charles River Laboratories
- CoJourney Inc
- Creative Biogene
- Flash-biosolutions
- Lonza
- ProBio CDMO
- ProBioGen AG
- Sartorius Stedim Biotech
- Takara Bio
- Thermo Fisher Scientific
- uBriGene
- VectorBuilder
- WuXi Advanced Therapies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 GMP Grade Viral Service Market by Type
- 1.2.1 Global GMP Grade Viral Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Viral Vector Process Development Service
- 1.2.3 Gmp Manufacturing and Release Service
- 1.2.4 Analytical Method Development and Quality Research Service
- 1.2.5 Others
- 1.3 GMP Grade Viral Service Market by Application
- 1.3.1 Global GMP Grade Viral Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Gene Therapy and Cell Therapy Industry
- 1.3.3 Tumor Immunotherapy Industry
- 1.3.4 Vaccine Industry
- 1.3.5 Diagnostics Industry
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 GMP Grade Viral Service Market Dynamics
- 2.1 GMP Grade Viral Service Industry Trends
- 2.2 GMP Grade Viral Service Industry Drivers
- 2.3 GMP Grade Viral Service Industry Opportunities and Challenges
- 2.4 GMP Grade Viral Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global GMP Grade Viral Service Market Perspective (2021-2032)
- 3.2 Global GMP Grade Viral Service Growth Trends by Region
- 3.2.1 Global GMP Grade Viral Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global GMP Grade Viral Service Market Size by Region (2021-2026)
- 3.2.3 Global GMP Grade Viral Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global GMP Grade Viral Service Revenue by Players
- 4.1.1 Global GMP Grade Viral Service Revenue by Players (2021-2026)
- 4.1.2 Global GMP Grade Viral Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global GMP Grade Viral Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global GMP Grade Viral Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global GMP Grade Viral Service Key Players Headquarters & Area Served
- 4.4 Global GMP Grade Viral Service Players, Product Type & Application
- 4.5 Global GMP Grade Viral Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global GMP Grade Viral Service Market CR5 and HHI
- 4.6.3 2025 GMP Grade Viral Service Tier 1, Tier 2, and Tier 3
5 GMP Grade Viral Service Market Size by Type
- 5.1 Global GMP Grade Viral Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global GMP Grade Viral Service Revenue by Type (2021-2032)
- 5.3 Global GMP Grade Viral Service Revenue Market Share by Type (2021-2032)
6 GMP Grade Viral Service Market Size by Application
- 6.1 Global GMP Grade Viral Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global GMP Grade Viral Service Revenue by Application (2021-2032)
- 6.3 Global GMP Grade Viral Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 AGC Biologics
- 7.1.1 AGC Biologics Company Information
- 7.1.2 AGC Biologics Business Overview
- 7.1.3 AGC Biologics GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.1.4 AGC Biologics GMP Grade Viral Service Product Portfolio
- 7.1.5 AGC Biologics Recent Developments
- 7.2 Andelyn Biosciences
- 7.2.1 Andelyn Biosciences Company Information
- 7.2.2 Andelyn Biosciences Business Overview
- 7.2.3 Andelyn Biosciences GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Andelyn Biosciences GMP Grade Viral Service Product Portfolio
- 7.2.5 Andelyn Biosciences Recent Developments
- 7.3 Catalent
- 7.3.1 Catalent Company Information
- 7.3.2 Catalent Business Overview
- 7.3.3 Catalent GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Catalent GMP Grade Viral Service Product Portfolio
- 7.3.5 Catalent Recent Developments
- 7.4 Charles River Laboratories
- 7.4.1 Charles River Laboratories Company Information
- 7.4.2 Charles River Laboratories Business Overview
- 7.4.3 Charles River Laboratories GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Charles River Laboratories GMP Grade Viral Service Product Portfolio
- 7.4.5 Charles River Laboratories Recent Developments
- 7.5 CoJourney Inc
- 7.5.1 CoJourney Inc Company Information
- 7.5.2 CoJourney Inc Business Overview
- 7.5.3 CoJourney Inc GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.5.4 CoJourney Inc GMP Grade Viral Service Product Portfolio
- 7.5.5 CoJourney Inc Recent Developments
- 7.6 Creative Biogene
- 7.6.1 Creative Biogene Company Information
- 7.6.2 Creative Biogene Business Overview
- 7.6.3 Creative Biogene GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Creative Biogene GMP Grade Viral Service Product Portfolio
- 7.6.5 Creative Biogene Recent Developments
- 7.7 Flash-biosolutions
- 7.7.1 Flash-biosolutions Company Information
- 7.7.2 Flash-biosolutions Business Overview
- 7.7.3 Flash-biosolutions GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Flash-biosolutions GMP Grade Viral Service Product Portfolio
- 7.7.5 Flash-biosolutions Recent Developments
- 7.8 Lonza
- 7.8.1 Lonza Company Information
- 7.8.2 Lonza Business Overview
- 7.8.3 Lonza GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Lonza GMP Grade Viral Service Product Portfolio
- 7.8.5 Lonza Recent Developments
- 7.9 ProBio CDMO
- 7.9.1 ProBio CDMO Company Information
- 7.9.2 ProBio CDMO Business Overview
- 7.9.3 ProBio CDMO GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.9.4 ProBio CDMO GMP Grade Viral Service Product Portfolio
- 7.9.5 ProBio CDMO Recent Developments
- 7.10 ProBioGen AG
- 7.10.1 ProBioGen AG Company Information
- 7.10.2 ProBioGen AG Business Overview
- 7.10.3 ProBioGen AG GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.10.4 ProBioGen AG GMP Grade Viral Service Product Portfolio
- 7.10.5 ProBioGen AG Recent Developments
- 7.11 Sartorius Stedim Biotech
- 7.11.1 Sartorius Stedim Biotech Company Information
- 7.11.2 Sartorius Stedim Biotech Business Overview
- 7.11.3 Sartorius Stedim Biotech GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Sartorius Stedim Biotech GMP Grade Viral Service Product Portfolio
- 7.11.5 Sartorius Stedim Biotech Recent Developments
- 7.12 Takara Bio
- 7.12.1 Takara Bio Company Information
- 7.12.2 Takara Bio Business Overview
- 7.12.3 Takara Bio GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.12.4 Takara Bio GMP Grade Viral Service Product Portfolio
- 7.12.5 Takara Bio Recent Developments
- 7.13 Thermo Fisher Scientific
- 7.13.1 Thermo Fisher Scientific Company Information
- 7.13.2 Thermo Fisher Scientific Business Overview
- 7.13.3 Thermo Fisher Scientific GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.13.4 Thermo Fisher Scientific GMP Grade Viral Service Product Portfolio
- 7.13.5 Thermo Fisher Scientific Recent Developments
- 7.14 uBriGene
- 7.14.1 uBriGene Company Information
- 7.14.2 uBriGene Business Overview
- 7.14.3 uBriGene GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.14.4 uBriGene GMP Grade Viral Service Product Portfolio
- 7.14.5 uBriGene Recent Developments
- 7.15 VectorBuilder
- 7.15.1 VectorBuilder Company Information
- 7.15.2 VectorBuilder Business Overview
- 7.15.3 VectorBuilder GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.15.4 VectorBuilder GMP Grade Viral Service Product Portfolio
- 7.15.5 VectorBuilder Recent Developments
- 7.16 WuXi Advanced Therapies
- 7.16.1 WuXi Advanced Therapies Company Information
- 7.16.2 WuXi Advanced Therapies Business Overview
- 7.16.3 WuXi Advanced Therapies GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 7.16.4 WuXi Advanced Therapies GMP Grade Viral Service Product Portfolio
- 7.16.5 WuXi Advanced Therapies Recent Developments
8 North America
- 8.1 North America GMP Grade Viral Service Revenue (2021-2032)
- 8.2 North America GMP Grade Viral Service Revenue by Type (2021-2032)
- 8.2.1 North America GMP Grade Viral Service Revenue by Type (2021-2026)
- 8.2.2 North America GMP Grade Viral Service Revenue by Type (2027-2032)
- 8.3 North America GMP Grade Viral Service Revenue Share by Type (2021-2032)
- 8.4 North America GMP Grade Viral Service Revenue by Application (2021-2032)
- 8.4.1 North America GMP Grade Viral Service Revenue by Application (2021-2026)
- 8.4.2 North America GMP Grade Viral Service Revenue by Application (2027-2032)
- 8.5 North America GMP Grade Viral Service Revenue Share by Application (2021-2032)
- 8.6 North America GMP Grade Viral Service Revenue by Country
- 8.6.1 North America GMP Grade Viral Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America GMP Grade Viral Service Revenue by Country (2021-2026)
- 8.6.3 North America GMP Grade Viral Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe GMP Grade Viral Service Revenue (2021-2032)
- 9.2 Europe GMP Grade Viral Service Revenue by Type (2021-2032)
- 9.2.1 Europe GMP Grade Viral Service Revenue by Type (2021-2026)
- 9.2.2 Europe GMP Grade Viral Service Revenue by Type (2027-2032)
- 9.3 Europe GMP Grade Viral Service Revenue Share by Type (2021-2032)
- 9.4 Europe GMP Grade Viral Service Revenue by Application (2021-2032)
- 9.4.1 Europe GMP Grade Viral Service Revenue by Application (2021-2026)
- 9.4.2 Europe GMP Grade Viral Service Revenue by Application (2027-2032)
- 9.5 Europe GMP Grade Viral Service Revenue Share by Application (2021-2032)
- 9.6 Europe GMP Grade Viral Service Revenue by Country
- 9.6.1 Europe GMP Grade Viral Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe GMP Grade Viral Service Revenue by Country (2021-2026)
- 9.6.3 Europe GMP Grade Viral Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China GMP Grade Viral Service Revenue (2021-2032)
- 10.2 China GMP Grade Viral Service Revenue by Type (2021-2032)
- 10.2.1 China GMP Grade Viral Service Revenue by Type (2021-2026)
- 10.2.2 China GMP Grade Viral Service Revenue by Type (2027-2032)
- 10.3 China GMP Grade Viral Service Revenue Share by Type (2021-2032)
- 10.4 China GMP Grade Viral Service Revenue by Application (2021-2032)
- 10.4.1 China GMP Grade Viral Service Revenue by Application (2021-2026)
- 10.4.2 China GMP Grade Viral Service Revenue by Application (2027-2032)
- 10.5 China GMP Grade Viral Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia GMP Grade Viral Service Revenue (2021-2032)
- 11.2 Asia GMP Grade Viral Service Revenue by Type (2021-2032)
- 11.2.1 Asia GMP Grade Viral Service Revenue by Type (2021-2026)
- 11.2.2 Asia GMP Grade Viral Service Revenue by Type (2027-2032)
- 11.3 Asia GMP Grade Viral Service Revenue Share by Type (2021-2032)
- 11.4 Asia GMP Grade Viral Service Revenue by Application (2021-2032)
- 11.4.1 Asia GMP Grade Viral Service Revenue by Application (2021-2026)
- 11.4.2 Asia GMP Grade Viral Service Revenue by Application (2027-2032)
- 11.5 Asia GMP Grade Viral Service Revenue Share by Application (2021-2032)
- 11.6 Asia GMP Grade Viral Service Revenue by Country
- 11.6.1 Asia GMP Grade Viral Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia GMP Grade Viral Service Revenue by Country (2021-2026)
- 11.6.3 Asia GMP Grade Viral Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA GMP Grade Viral Service Revenue (2021-2032)
- 12.2 SAMEA GMP Grade Viral Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA GMP Grade Viral Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA GMP Grade Viral Service Revenue by Type (2027-2032)
- 12.3 SAMEA GMP Grade Viral Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA GMP Grade Viral Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA GMP Grade Viral Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA GMP Grade Viral Service Revenue by Application (2027-2032)
- 12.5 SAMEA GMP Grade Viral Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA GMP Grade Viral Service Revenue by Country
- 12.6.1 SAMEA GMP Grade Viral Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA GMP Grade Viral Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA GMP Grade Viral Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst